rheumatoid arthritis

BMS rheumatoid arthritis drug clazakizumab causes a stir at ACR
Pharma Times, UK
Tue, 10/29/13 - 12:14 pm
rheumatoid arthritis
clazakizumab
Bristol-Myers Squibb
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
Vertex reports positive results from Phase 2 study of VX-509
Yahoo/The Fly on the Wall
Sat, 10/19/13 - 03:51 pm
Vertex Pharmaceuticals
VX-509
rheumatoid arthritis
Antares' Otrexup Approval Was Easy, Selling Drug Will be Hard
TheStreet.com
Mon, 10/14/13 - 10:44 am
Antares
Otrexup
rheumatoid arthritis
Antares' Otrexup Ready For FDA Approval
Seeking Alpha
Thu, 10/10/13 - 11:55 am
Otrexup
FDA
rheumatoid arthritis
Antares
devices
Knockoff Lust: AbbVie's $9 Billion-A-Year Humira
Seeking Alpha
Wed, 10/9/13 - 08:25 am
AbbVie
Humira
JNJ
Amgen
rheumatoid arthritis
Ablynx Rises on Drug Licensing Deal With AbbVie
Bloomberg
Mon, 09/23/13 - 09:17 am
Ablynx
AbbVie
ALX-0061
rheumatoid arthritis
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
EU approves biosimilar of J&J and Merck's Remicade, WSJ says
Yahoo/Fly on the Wall
Wed, 09/11/13 - 08:48 am
Europe
biosimilars
JNJ
Merck
Remicade
rheumatoid arthritis
Low-profile Epirus lays claim to a PhIII success for Remicade biosimilar
Fierce Biotech
Thu, 08/29/13 - 11:16 am
Epirus
biosimilars
Remicade
BOW-015
rheumatoid arthritis
Isis to stop developing rheumatoid arthritis drug
Reuters
Mon, 08/5/13 - 09:54 am
Isis Pharmaceuticals
rheumatoid arthritis
ISIS-CRPRx
FDA panel narrowly backs new use of UCB's arthritis drug
Reuters
Wed, 07/24/13 - 09:49 am
FDA
UCB Pharmaceuticals
rheumatoid arthritis
certolizumab
5 more countries OK Pfizer's Xeljanz
Yahoo/AP
Tue, 07/16/13 - 09:25 am
Pfizer
rheumatoid arthritis
Xeljanz
Biosimilar versions of Remicade given EU green light
Reuters
Fri, 06/28/13 - 10:15 am
Remicade
biosimilars
Europe
Celltrion
Remsima
Hospira
Inflectra
rheumatoid arthritis
How Important Is A New Label For Pfizer's Xeljanz?
Seeking Alpha
Wed, 06/26/13 - 01:30 am
Pfizer
Xeljanz
rheumatoid arthritis
Pfizer Announces FDA Acceptance for Review of Application to Expand Labeling for XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis to Include Inhibition of Progression of Structural Damage
Yahoo/BusinessWire
Sat, 06/22/13 - 09:44 am
rheumatoid arthritis
Xeljanz
Pfizer
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Humira
AbbVie
Galapagos
GLPG0634
Chron's Disease
Incyte
Eli Lilly
Pfizer
rheumatoid arthritis
Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?
Seeking Alpha
Sat, 06/15/13 - 12:58 pm
Amgen
Enbrel
rheumatoid arthritis
arthritis
generics
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Yahoo
Fri, 06/14/13 - 10:27 am
Bristol-Myers Squibb
China
Simcere
Orencia
rheumatoid arthritis
Lilly says arthritis pill effective in mid-stage study
Reuters
Thu, 06/13/13 - 10:45 am
Eli Lilly
Incyte
baricitinib
rheumatoid arthritis

Pages